Deputy Editor in Chief
The deputy editor in chief provides support to the editor in chief on editorial decision-making, and is responsible for editorial-decisions when the editor in chief is unavailable or has declared a conflict of interest.
Michael Linnebacher, PhD
Dr Michael Linnebacher is an immunologist and molecular biologist trained in Saarbrücken, Homburg and Heidelberg. He received his Ph.D. in 2001 from the University of Karlsruhe. In 2005 he went to Rostock, where he currently leads a group working on molecular oncology and immunotherapy with a strong focus on tissue banking and establishment of individual models of disease. Additional research interests focus on the development and evaluation of novel diagnostic assays and therapeutic strategies basing on neoantigens derived from mutations and reactivated endogenous retroviral sequences.
Supplement Guest Editors & Editorial Board Members
Supplement guest editors are responsible for the editorial content of published supplements, and as editorial board members are a source of peer reviewers and may occasionally provide assistance to the editor in chief. Further information on the editorial board is available here, and information on the roles of guest editors in supplements is available here.
Biomarkers for Colon Cancer:
David Barras, PhD
Bioinformatician, Bioinformatics Core Facility, Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Sevtap Savas, PhD
Associate Professor of Genetics and Oncology, Memorial University of Newfoundland, St. John’s, Canada.
Signaling Pathways as Biomarkers:
Anagh A. Sahasrabuddhe, PhD
Scientist/Ramanujan Fellow, Department of Biotechnology, Pandit Ravishankar Shukla University, Raipur, India.
Delphine C. M. Rolland, PhD
Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania,
Philadelphia, PA, USA.
Pinaki P. Banerjee, PhD
Director of Immunology & Project Management Kiromic Biopharma, Houston, TX, USA.
Editorial Board Members
The editorial board is the journal's primary source of peer reviewers and members occasionally provide assistance to the editor in chief. The editor in chief welcomes applications from suitable candidates to join the editorial board. Further information on the editorial board is available here.
Hafiz Ahmed, PhD
Assistant Professor, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine and Greenebaum Cancer Center, Baltimore, MD, USA
Graham Ball, PhD, BSc, FRSB
Professor of Bioinformatics, Science and Technology, Nottingham Trent University, Nottingham, UK
Alison Banham, MA, DPHil, FRCPath
Professor in Haemato-Oncology, Nuffield Department of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
Ancha Baranova, PhD, DSci
Associate Professor, Molecular and Microbiology Department, School of Systems Biology, College of Science, George Mason University, Fairfax, VA, USA
Ashish Chintakuntlawar, MD, PhD
Fellow, Mayo Clinic, Rochester, MN, USA
Jayanta K Das, PhD
Research Assistant Professor, Department of Environmental and Occupational Health, Florida International University, Miami, FL, USA
Janaina Fernandes, PhD
NUMPEX-BIO, Campus Xerém, Federal University of Rio de Janeiro, Duque de Caxias, Institute for Translational Research on Health and Environment in the Amazon Region—INPeTAm, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Luca Filippi, MD
Nuclear Medicine Physician, Department of Nuclear Medicine, Santa Maria Goretti Hospital, Latina, Italy
Gilles Guillemin, PhD, JP
Professor, Australian School of Advanced Medicine, Macquarie University; Co-Director, MND and Neurodegenerative diseases Research Centre, Macquarie University, Sydney, Australia
Oliver W. Hakenberg, MD, PhD, FEBU
Professor and Chairman, Urology, University Hospital, University of Rostock, Rostock, Germany
Kam Man Hui, PhD
Professor, Cancer Genomics, Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore
Shahram Kordasti, MD, PhD
Lecturer, Department of Haematological Medicine, King's College London, London, UK
Jon Amund Kyte, MD, PhD
Department of Oncology, The Cancer Clinic, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
Cindy Lee, PhD
Consultant Haematologist, Haematology, SA Pathology, Royal Adelaide Hospital, Adelaide, Australia
Wen-Rong Lie, PhD
Principal Scientist, Research and Development, Bioscience, EMD Millipore, St Charles, MO, USA
Aija Linē, PhD
Group Leader, Cancer Biomarker Group, Latvian Biomedical Research and Study Centre, Riga, Latvia
Ken Mills, PhD
Professor, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK
Steven R. Myers, PhD
Professor of Pharmacology and Toxicology, Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY, US
Alistair Noble, PhD
Senior Lecturer, Department of Asthma, Allergy & Respiratory Science, School of Medicine, King’s College London, London, UK
Adam Paige, PhD
Senior Lecturer in Biomedical Science, Department of Life Sciences, University of Bedfordshire, Park Square, Luton, UK
Cornelis F. M. Sier, PhD
Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
Bhuminder Singh, PhD
Research Scientist, Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA
Evelien Smits, PhD
Assistant Professor, Center for Oncological Research and Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
Masatoshi Tagawa, MD, PhD
Head, Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan
Mark Tangney, PhD
Principal Investigator, Cork Cancer Research Centre, University College Cork, Cork, Ireland
James Willey, MD
Professor, Medicine and Pathology, University of Toledo Health Sciences Campus, Toledo, OH, USA
Dexian Zheng, PhD
Professor, Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Xianfeng Zhou, PhD
Assistant Professor, Cener for Molecular Biology of Oral Diseases, University of Illinois at Chicago, Chicago, IL, USA
Zheying Zhu, PhD
Senior Lecturer in Pharmacology, Department of Life Sciences, University of Bedfordshire, UK
I had a great experience in publishing a review article in Biomarkers in Cancer. The submission process was extremely smooth and peer review was fast and channelized. At each and every step I was able to monitor the progress. Response to my communication was instant and every time confirmation emails were sent. The publication processing team provided excellent support for proof reading and corrections. I recommend publishing in it and wish them success. ...